RCUS Arcus Biosciences, Inc. logo

RCUS Arcus Biosciences, Inc.

Healthcare
$23.43-1.84%ClosedMarket Cap: $2.36B

As of 2026-05-25

Institutional Ownership Summary

Investors Holding

223

13F Shares

121,423,915

Ownership %

114.0%

New Positions

50

Increased Positions

148

Closed Positions

29

Reduced Positions

36

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
CNCRLoncar Cancer Immunotherapy ETF62,7653.32%
IDNAiShares Genomics Immunology and Healthcare ETF120,6241.72%
PSCHInvesco S&P SmallCap Health Care ETF61,1661.08%
CANCTema Oncology ETF74,7240.95%
BBCVirtus Biotech Clinical Trials ETF12,6640.79%
XBI2,163,3630.65%
LABUDirexion Daily S&P Biotech Bull 3X ETF108,3270.46%
XSMO423,4840.40%
DWASInvesco Dorsey Wright SmallCap Momentum ETF61,1540.37%
VSTCX197,7850.20%
VGHCX3,205,5650.19%
VGHAX3,205,5650.19%
IBBiShares Biotechnology ETF612,3550.16%
SLYGState Street SPDR S&P 600 Small Cap Growth ETF281,7360.15%
IJTiShares S&P Small-Cap 600 Growth ETF460,7690.15%
NLT460,7690.15%
FESMFidelity Enhanced Small Cap ETF274,2880.14%
VIOG60,0330.14%
IJRiShares Core S&P Small-Cap ETF5,087,8170.12%
NIRNear Intelligence, Inc.5,087,8170.12%